Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving Secretion of Insulin in New Onset Diabetes after Renal Transplantation (ISINODAT)
2009-012712-40Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of cyclosporine and tacrolimus in diabetes mellitus (DM) (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Change in OGTT performance at day 90 and Change in OGTT performance at day 180. Started Jul 2009; status: completed.
02
Drugs
cyclosporinetacrolimus
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on 2009-012712-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012712-40.